Parsaclisib
Parsaclisib Uses, Dosage, Side Effects, Food Interaction and all others data.
Parsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).
Trade Name | Parsaclisib |
Generic | Parsaclisib |
Parsaclisib Other Names | INCB050465, Parsaclisib |
Type | |
Formula | C20H22ClFN6O2 |
Weight | Average: 432.88 Monoisotopic: 432.1476798 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Parsaclisib